Can a 4-Week Pre-Surgery boost cut complications in GI cancer surgery?
NCT ID NCT06404489
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a 4-week program of exercise, nutrition advice, and stress management before major gastrointestinal cancer surgery can reduce serious complications within 30 days after the operation. About 400 adult patients scheduled for elective GI cancer surgery will take part. The program is tailored to each patient's needs and aims to improve their physical and mental readiness for surgery.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Multimodal prehabilitation program (exercise, nutrition optimization, and distress-coping techniques)
What this could lead to
If it works, this could reduce serious complications and shorten hospital stays for people undergoing major gastrointestinal cancer surgery.
What could go wrong
This is a single-center study with 400 participants, and the program is tailored individually, so results may not apply to all patients or hospitals. The intervention is behavioral, so adherence and effectiveness can vary.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTROINTESTINAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Azienda Ospedaliera Universitaria
Cagliari, Sardinia, Italy
-
IRCCS San Raffaele Scientific Institute
Milan, 20132, Italy